[What are the treatment possibilities for myelodysplastic syndrome?].
von Wichert
P
P
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors
Welche Behandlungsmöglichkeiten bestehen für myelodysplastische Syndrome?